LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Dec 15, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-12-14

Reporting Person: Pecora Andrew L (Director, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-14	Common Stock, $0.001 par value	P	40000	$0.59	Acquired	1995504	Direct
2011-12-15	Common Stock, $0.001 par value	P	10000	$0.60	Acquired	2005504	Direct